NCT01793116

Brief Summary

This is a registry of moderate preterm infants, born alive at 29-33 weeks gestational age, in NICHD Neonatal Research Network (NRN) centers. The registry collects observational baseline data on both mothers and infants, and the therapies used and outcomes of the infants. The information collected is not specific to a disease or treatment (i.e., it is "generic"). Data are analyzed to find associations and trends between baseline information, treatments, and infant outcome, and to develop future NRN trials.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7,057

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2012

Geographic Reach
1 country

19 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2012

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

February 13, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 15, 2013

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2013

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2014

Completed
Last Updated

March 22, 2019

Status Verified

March 1, 2019

Enrollment Period

1.6 years

First QC Date

February 13, 2013

Last Update Submit

March 20, 2019

Conditions

Keywords

NICHD Neonatal Research NetworkModerately Preterm

Outcome Measures

Primary Outcomes (1)

  • Number of infants born moderately preterm

    Number of infants born between 29-33 weeks gestational age at 18 participating NRN centers.

    up to 2 years

Eligibility Criteria

Age29 Weeks - 33 Weeks
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Moderately preterm infants born at 29 0/7 weeks to 33 6/7 weeks-both inborn and outborn but admitted prior to 72 hours at NRN centers will be included in this study.

You may qualify if:

  • Gestational age 29-33 weeks
  • Inborn infants and outborn infants admitted by 72 hours.

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (19)

University of Alabama at Birmingham

Birmingham, Alabama, 35233, United States

Location

University of California - Los Angeles

Los Angeles, California, 90025, United States

Location

Stanford University

Palo Alto, California, 94304, United States

Location

Emory University

Atlanta, Georgia, 30303, United States

Location

Indiana University

Indianapolis, Indiana, 46202, United States

Location

University of Iowa

Iowa City, Iowa, 52242, United States

Location

Wayne State University

Detroit, Michigan, 48201, United States

Location

Children's Mercy Hospital

Kansas City, Missouri, 64108, United States

Location

University of New Mexico

Albuquerque, New Mexico, 87131, United States

Location

University of Rochester

Rochester, New York, 14642, United States

Location

RTI International

Durham, North Carolina, 27705, United States

Location

Duke University

Durham, North Carolina, 27710, United States

Location

Cincinnati Children's Medical Center

Cincinnati, Ohio, 45267, United States

Location

Case Western Reserve University, Rainbow Babies and Children's Hospital

Cleveland, Ohio, 44106, United States

Location

Research Institute at Nationwide Children's Hospital

Columbus, Ohio, 43205, United States

Location

Univeristy of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Location

Brown University, Women & Infants Hospital of Rhode Island

Providence, Rhode Island, 02905, United States

Location

University of Texas Southwestern Medical Center at Dallas

Dallas, Texas, 75235, United States

Location

University of Texas Health Science Center at Houston

Houston, Texas, 77030, United States

Location

Related Links

Study Officials

  • Abbot R Laptook, MD

    Brown University, Women & Infants Hospital of Rhode Island

    PRINCIPAL INVESTIGATOR
  • Michele C Walsh, MD, MS

    Case Western Reserve University, Rainbow Babies and Children's Hospital

    PRINCIPAL INVESTIGATOR
  • Ronald N Goldberg, MD

    Duke University

    PRINCIPAL INVESTIGATOR
  • Barbara J Stoll, MD

    Emory University

    PRINCIPAL INVESTIGATOR
  • Brenda B Poindexter, MD, MS

    Indiana University

    PRINCIPAL INVESTIGATOR
  • Abhik Das, PhD

    RTI International

    PRINCIPAL INVESTIGATOR
  • Krisa P Van Meurs, MD

    Stanford University

    PRINCIPAL INVESTIGATOR
  • Kurt Schibler, MD

    Children's Hospital Medical Center, Cincinnati

    PRINCIPAL INVESTIGATOR
  • Waldemar Carlo, MD

    University of Alabama at Birmingha

    PRINCIPAL INVESTIGATOR
  • Edward F Bell, MD

    University of Iowa

    PRINCIPAL INVESTIGATOR
  • Kristi L Watterberg, MD

    University of New Mexico

    PRINCIPAL INVESTIGATOR
  • Pablo J Sanchez, MD

    University of Texas, Southwestern Medical Center at Dallas

    PRINCIPAL INVESTIGATOR
  • Kathleen A Kennedy, MD, MPH

    The University of Texas Health Science Center, Houston

    PRINCIPAL INVESTIGATOR
  • Seetha Shankaran, MD

    Wayne State University

    PRINCIPAL INVESTIGATOR
  • William Truog, MD

    Abbot R Laptook, MD Study Principal Investigator Brown University, Women & Infants Hospital of Rhode Island Michele C Walsh, MD MS Study Principal Investigator Case Western Reserve University, Rainbow Babies and Children's Hospital Ronald N Goldberg,

    PRINCIPAL INVESTIGATOR
  • Barbara Schmidt, MD, MSc

    University of Pennsylvania

    PRINCIPAL INVESTIGATOR
  • Carl D'Angio, MD

    University of Rochester

    PRINCIPAL INVESTIGATOR
  • Uday Devaskar, MD

    University of California, Los Angeles

    PRINCIPAL INVESTIGATOR
  • Leif Nelin, MD

    Research Institute at Nationwide Children's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
11 Weeks
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 13, 2013

First Posted

February 15, 2013

Study Start

March 1, 2012

Primary Completion

October 1, 2013

Study Completion

February 1, 2014

Last Updated

March 22, 2019

Record last verified: 2019-03

Locations